Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment of Antipsychotic-associated Obesity With a GLP-1 Analogue

NCT01794429 is registered in ClinicalTrials.gov with Bjorn H. Ebdrup as lead sponsor.

NCT NCT01794429
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01794429 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment of Antipsychotic-associated Obesity With a GLP-1 Analogue
Lead sponsor
Bjorn H. Ebdrup
Phase
Phase 3
Overall status
Completed
Start date
February 28, 2013
Completion date
June 30, 2015
Enrollment
45 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

drug-induced obesity, metabolic syndrome x, obesity, schizophrenia